Laboratory of Structural Biology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Protein Eng Des Sel. 2013 Sep;26(9):539-46. doi: 10.1093/protein/gzt033. Epub 2013 Jul 5.
The Alzheimer's disease-related protein, tau, aggregates into neurofibrillary tangles when it is hyperphosphorylated. The amino acid sequence included in the third repeat (R3) of the microtubule-binding region is suspected to be the main factor for tau aggregation. Here, we synthesized a 31-residue oligopeptide, corresponding to the R3 region, and characterized its aggregation propensity under various conditions. This peptide aggregated even in the absence of an aggregation-inducing molecule at a low salt concentration, while it did not form any aggregates at a high salt concentration. This suggests that hydrophilic interactions are the main cause of aggregation. We then investigated the function of FK506-binding protein (FKBP) 12, which is known to accumulate in neurofibrillary tangles in vivo, on aggregation of the R3 peptide and found that FKBP12 completely prevented the peptide from aggregating at a concentration ratio of 1 : 4 (peptide:FKBP12). FKBP12 also restored the oligomer of the peptide to its monomeric status. Mutational studies on the catalytic center of FKBP12 indicated that peptidyl-prolyl isomerase activity of FKBP12 was essential for prevention of aggregation. Assuming that the propensity of aggregation of the peptide is different in each cis-/trans-isomer, we propose that the aggregation behavior of the R3 peptide can be theoretically described with a simple kinetic scheme, in which only the cis-isomer can aggregate and FKBP12 catalyzes isomerization of the peptide in both the monomeric and aggregative states.
阿尔茨海默病相关蛋白 tau 在过度磷酸化时会聚集形成神经纤维缠结。微管结合区的第三个重复(R3)中的氨基酸序列被怀疑是 tau 聚集的主要因素。在这里,我们合成了一个包含 31 个残基的寡肽,对应于 R3 区域,并在各种条件下表征了其聚集倾向。该肽即使在低盐浓度下没有聚集诱导分子也会聚集,而在高盐浓度下则不会形成任何聚集物。这表明亲水相互作用是聚集的主要原因。然后,我们研究了 FK506 结合蛋白(FKBP)12 的功能,FKBP12 已知在体内神经纤维缠结中积累,发现 FKBP12 以 1:4(肽:FKBP12)的浓度比完全阻止了肽的聚集。FKBP12 还将肽的低聚物恢复为其单体状态。FKBP12 催化中心的突变研究表明,FKBP12 的肽基脯氨酰顺反异构酶活性对于防止聚集是必不可少的。假设肽的聚集倾向在每个顺式/反式异构体中不同,我们提出 R3 肽的聚集行为可以用一个简单的动力学方案来理论描述,其中只有顺式异构体可以聚集,而 FKBP12 可以催化单体和聚集状态下的肽异构化。